Screening for breast cancer is receiving increased emphasis with the development of modern technology. Health care providers must inform the public that screening for breast cancer may increase survival. Legislation must be enacted to ensure that a screening examination is affordable and can be readily...
This guideline updates the American Cancer Society breast cancer screening recommendations for women at average risk for breast cancer.
Breast Cancer Res. 2022;24(1):37. doi:10.1186/s13058-022-01533-zPubMedGoogle ScholarCrossref 23. Niraula S, Biswanger N, Hu P, Lambert P, Decker K. Incidence, characteristics, and outcomes of interval breast cancers compared with screening-detected breast cancers. ...
To estimate the impact of early detection of cancer, knowledge of how quickly primary tumors grow and at what size they shed lethal metastases is critical.
The sensitivity of a mammography program is normally evaluated by comparing the interval cancer rate to the expected breast cancer incidence without screening, i.e. the proportional interval cancer rate (PICR). The expected breast cancer incidence in absence of screening is, however, difficult to ...
PubMed ID:: 2406115 Keywords: Breast Neoplasms,diagnosis,prevention & control,therapy,Combined Modality Therapy,Female,Humans,Mass Screening,Neoplasm Metastasis Data availability: Keywords: Breast Neoplasms, diagnosis, prevention & control, therapy, Combined Modality Therapy, Female, Humans, Mass Screenin...
While IBCs do not represent a unique molecular class of invasive breast cancer they exhibit a more aggressive phenotype, which is likely to be a consequence of the timing of tumour initiation. This information is relevant both with respect to treatment as well as informing the screening interval ...
The tumour immune microenvironment is shaped by the crosstalk between cancer cells, immune cells, fibroblasts, endothelial cells and other stromal components. Although the immune tumour microenvironment (TME) serves as a source of therapeutic targets, it
Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-884. doi:10.1001/jamaoncol.2021.0884 ArticlePubMedGoogle ScholarCrossref 3. Guan A, Lichtensztajn D, Oh D, et al; San Francisco Cancer Initiative Breast...
Breast cancer screening by a combination of clinical breast examination (CBE) and mammography is effective in reducing mortality from breast cancer in all